Acne
Market Access/ News/ News/ Top stories
FDA hands Cassiopea its first approval, for acne drug Winlevi
Phil Taylor
Acne, Cassiopea, dermatology, FDA approval, Winlevi
0 Comment
X
FDA hands Cassiopea its first approval, for acne drug Winlevi
https://pharmaphorum.com/news/fda-hands-cassiopea-its-first-approval-for-acne-drug-winlevi/
X
Foamix to file acne treatment after successful late-stage trials
https://pharmaphorum.com/news/foamix-to-file-acne-treatment-after-successful-late-stage-trials/
Sienna loses a quarter of its value over pivotal trial failure
Piotr Wnuk
Acne, dermatology, Sienna Biopharmaceuticals
0 Comment
X
Sienna loses a quarter of its value over pivotal trial failure
https://pharmaphorum.com/news/sienna-loses-a-quarter-of-its-value-over-phase-3-trial-failure/